Importance Malignant primary brain tumors cause more than 15 000 deaths per year in the
United States. The annual incidence of primary malignant brain tumors is approximately 7 …

Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials
have been conducted to guide clinical decision making, resulting in variations of …

Meningiomas present as intracranial extra-axial lesions with dural attachment, which are
primarily managed surgically. The extent of resection (EOR) may vary depending on patient …

Surgery is the mainstay of treatment for meningioma, the most common primary intracranial
tumor, but improvements in meningioma risk stratification are needed and indications for …

Meningiomas are the most common intracranial tumors. Most meningiomas are WHO grade
1 tumors whereas less than one-quarter of all meningiomas are classified as atypical (WHO …

Background Surgery is the main treatment modality for intracranial meningiomas, but data
on short-term surgical outcome are limited. The aim of this Swedish nationwide registry …

Purpose Social determinants of health broadly affect healthcare access and outcomes.
Studies report that minorities and low socioeconomic status (SES) patients undergoing …

Simple Summary Intracranial meningiomas account for 30% to 40% of the primary lesions of
the central nervous system. Surgery is the mainstay treatment whenever symptoms related …

BACKGROUND Meningiomas are the most common tumors occurring in the central nervous
system, with variable recurrence rates depending on World Health Organization grading …

BACKGROUND Atypical meningiomas (AMs) are meningiomas that have a higher rate of
recurrence than grade I meningioma. Due to the higher risk of recurrence, adjuvant …